Document is current

Any future updates will be listed below

Summary of Research: Efficacy of Trastuzumab Deruxtecan in HER2-Expressing Solid Tumors by Enrollment HER2 IHC Status: Post Hoc Analysis of DESTINY-PanTumor02

Crossref DOI link: https://doi.org/10.1007/s12325-024-03080-9

Published Online: 2025-03-06

Published Print: 2025-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark